NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
Kulke
Matthew H
MH
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA 02115, USA. Matthew_kulke@dfci.harvard.edu
Anthony
Lowell B
LB
Bushnell
David L
DL
de Herder
Wouter W
WW
Goldsmith
Stanley J
SJ
Klimstra
David S
DS
Marx
Stephen J
SJ
Pasieka
Janice L
JL
Pommier
Rodney F
RF
Yao
James C
JC
Jensen
Robert T
RT
D005770:Gastrointestinal Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D018358:Neuroendocrine Tumors / Q000473:pathology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000473:pathology / Q000628:therapy*